Detalhe da pesquisa
1.
ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder.
Am J Hum Genet
; 104(2): 319-330, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30639322
2.
ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder.
Am J Hum Genet
; 106(1): 137, 2020 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879022
3.
Androgen receptor-mediated transcriptional repression targets cell plasticity in prostate cancer.
Mol Oncol
; 16(13): 2518-2536, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919781
4.
Fluorine NMR study of proline-rich sequences using fluoroprolines.
Magn Reson (Gott)
; 2(2): 795-813, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905223
5.
Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
Hum Mutat
; 31(1): 74-80, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19830810
6.
Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer.
Adv Exp Med Biol
; 617: 529-34, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18497078
7.
A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions.
Endocrinology
; 148(9): 4334-43, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17540719
8.
Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer.
Oncotarget
; 8(42): 72008-72020, 2017 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29069764
9.
A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer.
Eur J Endocrinol
; 148(1): 99-110, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12534363
10.
Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells.
PLoS One
; 8(5): e63466, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23658830
11.
Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.
PLoS One
; 7(8): e42252, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22879924
12.
Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation--a new paradigm for cooperation among prostate tumor cells.
Int J Cancer
; 121(6): 1238-44, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17534890
13.
Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer.
Int J Cancer
; 108(1): 152-7, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14618630